Cohort profile: the CORDELIA study (Collaborative cOhorts Reassembled Data to study mEchanisms and Longterm Incidence of chronic diseAses)
- PMID: 40353978
- PMCID: PMC12170779
- DOI: 10.1007/s10654-025-01229-6
Cohort profile: the CORDELIA study (Collaborative cOhorts Reassembled Data to study mEchanisms and Longterm Incidence of chronic diseAses)
Abstract
The CORDELIA Study (Collaborative Cohorts Reassembled Data to Study Mechanisms and Long-term Incidence of Chronic Diseases) combines 35 Spanish population cohorts to investigate the clinical, environmental, genetic, and omics determinants of cardiovascular disease in the Southern European population. It aims to conduct the largest genome-wide association study to date on cardiovascular disease in this population, improve predictions of cardiovascular incidence using genomic and clinical data, and identify subgroups that would benefit most from targeted pharmacological and lifestyle interventions. CORDELIA includes 196,632 individuals (ages 18-84, 54% female, 96% born in Spain, 20% with higher education, recruited from 1989 to 2020, with follow-up periods ranging from 5 to 30 years), with DNA samples available for 117,342 participants (60%). Of the participants, 24% were current smokers, 43% hypertensive, 11% diabetic, 15% medicated with lipid-lowering drugs, 44% overweight, and 27% obese. If not already available, genotyping is being performed using the Axiom™ Spain Biobank array (~ 750,000 variants, including 115,000 specific and 50,000 rare functional variants from the Spanish population). The cohort also includes incident events (coronary heart disease, stroke, heart failure, peripheral artery disease, hypertension, diabetes); date and cause of death; and harmonized data on risk factors (body mass index, waist circumference, lipid profile, blood pressure, glucose, creatinine), lifestyle (smoking, physical activity, diet, alcohol), and socioeconomic status. 99,019 participants (50%) also provide plasma samples. CORDELIA will significantly contribute to understanding the complex interplay of risk factors contributing to cardiovascular disease and advance the fields of precision medicine and public health in Southern European individuals.
Keywords: Cardiovascular disease; Cohort; Genome-wide association study; Mortality; Southern Europe.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors have no relevant financial or non-financial interests to disclose. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval for the CORDELIA Study was granted by the Ethics Committee of the Parc de Salut Mar (2023/10785/I, date: March 29, 2023). All cohorts have obtained informed consent by their participants and were approved by the corresponding ethics committees. The original informed consents have been expanded for this study by applying the Additional Disposition 17.2.C of the Spanish Organic Law 3/2018 on the Protection of Personal Data and the guarantee of digital rights, which allow for participant follow-up, aggregation of anonymized data, and the analyses described in this project. Extended information about ethical approval in the individual cohorts is available in Appendix III. Consent to participate: All participants in the CORDELIA cohorts agreed to participate after providing written informed consent for each cohort. Participants were given the option to decline their participation in the CORDELIA project through a document made available online in the websites of the individual cohorts, in accordance with Spanish law.
References
-
- GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–61. - PMC - PubMed
-
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources